Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...
Prescription drugs are still in the dark ages, but as we wait for science to catch up, smart modeling predicts problems before they happen. That’s a question that a team of scientists from the UCSF ...
In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused them of being far more likely to violate 340B Drug Pricing Program rules. In ...
New approach methodologies (NAMs) aim to streamline early-stage drug discovery and revolutionize preclinical testing by replacing traditional animal-based models with human-relevant insights, directly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback